Business & Industry
Business & Industry
Driving Documentation Integrity Through Structured Drug Data
Establishing a robust framework for regulatory success requires moving beyond fragmented information silos toward a unified, digital-first approach. Comprehensive oversight of the pharmaceutical lifecycle depends on the ability to transform raw information into actionable insights, ensuring that every data point contributes to a larger narrative of safety and efficacy. By prioritizing specialized platforms that aggregate and organize complex information, organizations can achieve a level of transparency that satisfies the most stringent global standards while fostering a culture of continuous improvement.
Business & Industry
J&J to Invest $1 Billion in Pennsylvania Cell Therapy Plant
Johnson & Johnson announced that it plans to invest more than $1 billion to construct a new cell therapy facility in Pennsylvania. The move forms part of the companyโs broader strategy, unveiled last year, to expand its U.S. manufacturing...
Business & Industry
FDA Approves Monthly Rybrevant Faspro for EGFR-Mutated NSCLC
Johnson & Johnson (J&J) has obtained approval from the US Food and Drug Administration (FDA) for a revised dosing schedule of Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), introducing a once-monthly administration option for patients with advanced, epidermal growth factor receptor...
Business & Industry
Sanofi to Expand Its Global Capability Centre in Hyderabad
In a move that is sure to create a stir within the Asia pharma circle, Sanofi Healthcare India - SHIPL is going ahead and expanding its GCC- global capability centre in Hyderabad, Telangana State with another 2.7 lakh sq.ft....
Business & Industry
Gilead Secures GH31 Global Rights in $80M Oncology Deal
Gilead Sciences has added another synthetic lethal asset to its oncology portfolio, agreeing to pay $80 million upfront to obtain global rights to a clinic-ready cancer therapy from China-based Genhouse Bio.
Headquartered in Suzhou, Genhouse Bio has been advancing its...
Business & Industry
Weight-Loss Pills Mark a Turning Point for Pharma Industry
The global pharmaceutical industry is entering a pivotal phase in obesity therapeutics as companies accelerate the transition from injectable GLP-1 drugs to oral weight-loss treatments, a shift expected to significantly expand patient access, alter reimbursement dynamics, and intensify competitive...
Business & Industry
Smart Factories Driving Innovations in Pharma Industry 4.0
The rise of smart factories in the pharmaceutical sector is characterized by the integration of AI, IoT, and real-time analytics to create highly efficient production ecosystems.
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















